MedTrace Logo

Post Burn Pruritus Study in Patients Undergoing Wound Healing

NCT00137202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2008-07-28

No results posted yet for this study

Summary

The purpose of this study is to see if a drug called ondansetron (Zofran) controls itching from healing burn wounds as well or better than the usual drug used, diphenhydramine (Benadryl).

Conditions

  • Itching

Interventions

DRUG

Ondansetron (Zofran)

DRUG

Diphenhydramine (Benadryl)

Sponsors & Collaborators

  • United States Army Institute of Surgical Research

    lead FED

Principal Investigators

  • Stuart Gross, MD · Wilford Hall Medical Center, Lackland AFB, San Antonio, TX

  • Steven E Wolf, MD · US Army Institute of Surgical Research, Fort Sam Houston, TX

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2006-05-31
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00137202 on ClinicalTrials.gov